CH503010A - Verfahren zur Herstellung von A-Nor-Steroiden der Gonan-, Androstan- und Östran-Reihen - Google Patents

Verfahren zur Herstellung von A-Nor-Steroiden der Gonan-, Androstan- und Östran-Reihen

Info

Publication number
CH503010A
CH503010A CH1529766A CH1529766A CH503010A CH 503010 A CH503010 A CH 503010A CH 1529766 A CH1529766 A CH 1529766A CH 1529766 A CH1529766 A CH 1529766A CH 503010 A CH503010 A CH 503010A
Authority
CH
Switzerland
Prior art keywords
hydroxy
methyl
gonan
ethyl
sep
Prior art date
Application number
CH1529766A
Other languages
German (de)
English (en)
Inventor
Jacques Jean
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH503010A publication Critical patent/CH503010A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1529766A 1965-10-21 1966-10-21 Verfahren zur Herstellung von A-Nor-Steroiden der Gonan-, Androstan- und Östran-Reihen CH503010A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50034465A 1965-10-21 1965-10-21
US56400566A 1966-07-11 1966-07-11

Publications (1)

Publication Number Publication Date
CH503010A true CH503010A (de) 1971-02-15

Family

ID=27053485

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1529766A CH503010A (de) 1965-10-21 1966-10-21 Verfahren zur Herstellung von A-Nor-Steroiden der Gonan-, Androstan- und Östran-Reihen

Country Status (5)

Country Link
BR (1) BR6683858D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH503010A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE1593099A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1169739A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL6614986A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60258171A (ja) * 1984-06-04 1985-12-20 Showa Denko Kk エピクロルヒドリンの製造方法

Also Published As

Publication number Publication date
BR6683858D0 (pt) 1973-12-04
GB1169739A (en) 1969-11-05
DE1593099A1 (de) 1970-06-18
NL6614986A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1967-04-24

Similar Documents

Publication Publication Date Title
CH561739A5 (en) 4-Hydroxy-2-butenoic acid lactone steroid derivs - cardiotonic, anti-inflammatory, hypocholesterolaemic, mineralocorticoid agents
CH503010A (de) Verfahren zur Herstellung von A-Nor-Steroiden der Gonan-, Androstan- und Östran-Reihen
DE1568308B2 (de) Verfahren zur herstellung von delta hoch 4,9,11-trienen der 19-nor- androstanreihe, 17-oxygenierte 3-oxo- 7 alpha-methyl-delta hoch 4,9,11-19 nor- androstatriene und diese enthaltende pharmazeutische praeparate sowie 3-oxo-7 alpha -methyl-delta hoch 5 (10), 9 (11) -19-nor- androstadiene
CH550156A (de) Verfahren zur herstellung von 3,6-dihydroxy-(delta)5(10)-steroiden.
DE1793641C2 (de) Verfahren zur Herstellung von 17-Halogenalkinyl 3-ketogonen und deren Verwendung. Ausscheidung aus: 1468988
DE1593052C3 (de) Verfahren zur Herstellung von 16-Methylen-19-norprogesteron-derivaten
US3270007A (en) Process for cyclopentanophenanthrene compounds
DE2043404A1 (de) 7beta Alkjl steroide und Verfahren zu ihrer Herstellung
DE1468985A1 (de) 17alpha-Alkyl-,17alpha-Alkenyl- und 17alpha-Alkinyl-4,5-epoxy-19-norandrostan-17beta-diole und deren Carbonsaeureester sowie Verfahren zur Herstellung dieser Verbindungen
AT271759B (de) Verfahren zur Herstellung von neuen 1,2β-Methylensteroiden
DE1793608B1 (de) 17alpha-Alkyl-,-Alkenyl- oder -Alkinyl-13ss-alkylgon-4-oder-5(10)-en-17ss-ol-3-one
CH495965A (de) Verfahren zur Herstellung von Steroiden der Östranreihe
DE1468988C (de) nalpha-Chloräthinyl-lSbeta-äthyl-4-oder-5( 10)- gonen-3 -ketone.'
DE883603C (de) Verfahren zur Herstellung von Verbindungen der Steroidreihe mit Sauerstoff in 11-Stellung
DE1568052C3 (de) 3beta-Acetoxy-5alpha-hydroxy-17 alpha-brompregnan-6, 20-dion sowie Verfahren zur Herstellung von 3beta, 5alpha-Dihydroxy-17alpha-methyl-17 beta-Carbo-methoxyandrostan-6-on
DE909935C (de) Verfahren zur Herstellung von í¸-3-Oxysteroiden oder ihren Derivaten
DE1199767B (de) Verfahren zur Herstellung von 1alpha-Methyl-A2-5alpha-androsten-17beta-olen
CH540894A (de) Verfahren zur Herstellung neuer 17a-Propadienylverbindungen der Steroidreihe
DE1199263B (de) Verfahren zur Herstellung von 17-(2-Alkenyl)-bzw. 17-(2-Alkinyl)-oestra-1, 3, 5(10)-trien-3, 17beta-diolen sowie von deren Estern
DE1443636A1 (de) Verfahren zur Herstellung neuer Methylandrostene
DE1593100A1 (de) Steroidverbindungen und Verfahren zu ihrer Herstellung
DE1443667B2 (de) Verfahren zur Herstellung von 11 beta, 18-Oxldo-18,21 -dihydroxy-20-oxopregnanverbindungen bzw. deren 21-Ester sowie Delta hoch 20 -11 beta, 18,20-Bisoxidopregnen-Zwischenprodukte
DE1923746A1 (de) 9beta,10Alpha-Steroide
DE1618960A1 (de) Neue Steroide und Verfahren zu ihrer Herstellung
DE1010962B (de) Verfahren zur Herstellung von 17-Alkyl-19-nortestosteronen

Legal Events

Date Code Title Description
PL Patent ceased